Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene

Cell Growth and Differentiation

Volumn 8, Issue 6, 1997, Pages 667-676

  Liu, Jingwen ^a   Spence, Michael J ^a   Wallace, Philip M ^b   Forcier, Kristin ^a   Hellström, Ingegerd ^b   Vestal, Robert E ^a,c  

^a Boise VA Medical Center   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL RECEPTOR; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

ARTICLE; BREAST CANCER; CANCER CELL; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR BINDING;

ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BREAST NEOPLASMS; CELL DIVISION; DOWN-REGULATION; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; GENES, MYC; GROWTH INHIBITORS; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LYMPHOKINES; ONCOSTATIN M; PEPTIDES; PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CYTOKINE; RECEPTORS, ONCOSTATIN M; RECEPTORS, OSM-LIF; TUMOR CELLS, CULTURED;

EID: 0030977678     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Zarling, J. M., Shoyab, M., Marquardt, H., Hanson, M. B., Lioubin, M. N., and Todaro, G. J. Oncostatin M: a growth regulator produced by differentiated lymphoma cells. Proc. Natl. Acad. Sci. USA, 83: 9739-9743, 1986.
2. Brown, T. J., Lioubin, M. N., and Marquardt, H. Purification and characterization of cytostatic lymphokines produced by activated human T-lymphocytes: synergistic antiproliferative activity of transforming growth factor β1, interferon γ, and oncostatin M for human melanoma cells. J. Immunol., 139: 2977-2983, 1987.
3. Grove, R. I., Mazzucco, C., Allegretto, N., Kiener, P. A., Spitalny, G., Radka, S. F., Shoyab, M., Antonaccio, M., and Warr, G. A. Macrophage-derived factors increase low-density lipoprotein uptake and receptor number in cultured human liver cells. J. Lipid Res., 32: 1889-1897, 1991.
4. Grove, R. I, Eberhardt, C., Abid, S., Mazzucco, C., Liu, J., Todaro, G., Kiener, P., and Shoyab, M. Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA, 90: 823-827, 1993.
5. Zhang, X. G., Gu, J. J., Lu, Z. Y., Yasukawa, K., Yancopoulos, G. D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T., Bataille, R., and Klein, B. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J. Exp. Med., 179: 1343-1347, 1994.
6. Horn, D., Fitzpatrick, W. C., Gompper, P. T., Ochs, V., Bolton-Hansen, M., Zarling, J. M., Malik, N., Todaro, G. J., and Linsley, P. S. Regulation of cell growth by recombinant oncostatin M. Growth Factors, 2: 157-165, 1990.
7. Liu, J., Clegg, H. C., and Shoyab, M. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M. Cell Growth & Differ., 3: 307-313, 1992.
8. Gearing, D. P., and Bruce, A. G. Oncostatin M binds the high-affinity leukemia inhibitory factor. New Biol., 4: 61-65, 1991.
9. Gearing, D. P., Comeau, M. R., Friend, D. J., Gimpel, S., Thut, C. J., McGourty, J., Brasher, K. K., Kinh, J. A., Gillis, S., Mosley, B., Ziegler, S. F., and Cosman, D. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science (Washington DC), 255: 1434-1437, 1992.
10. Liu, J., Modrell, B., Aruffo, A., Marken, J. S., Taga, T., Yasukawa, K., Murakami, M., Kishimoto, T., and Shoyab, M. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J. Biol. Chem., 267: 16763-16766, 1992.
11. Pennica, D. Cardiotrophin-1: biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem., 270: 10915-10922, 1995.
12. Mosley, B., Imus, C. D., Friend, D., Boian, N., Thoma, B., Park, L., and Cosman, D. Dual oncostatin M (OSM) receptors: cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem., 271: 32635-32643, 1996.
13. Liu, J., Modrell, B., Aroffo, A., Schamowske, S., and Shoyab, M. Interactions between oncostatin M and the IL-6 signal transducer, gp130. Cytokine, 6: 272-278, 1994.
14. Lai, L., Kadory, S., Siraj, A. K., and Lennard, T. W. J. Oncostatin M, interleukin 2, interleukin 6, and interleukin 8 in breast cyst fluid. Int. J. Cancer, 59: 369-372, 1994.
15. Dixon, J. M., Lumsden, A. B., and Miller, W. R. The relationship of cyst type to risk factors for breast cancer in patients with breast cystic disease. Eur. J. Cancer Clin. Oncol., 21: 1047-1050, 1985.
16. Boccardo, F., Zanardi, S., Valenti, G., Cannata, D., Maisto, L., Nicolo, G., Barreca, A., Del Monte, P., and Minuto, F. Epidermal growth factor in breast cyst fluid: relationships with the morphology of cyst epithelium. Ann. NY Acad. Sci., 586: 137-142, 1990.
17. Colomb, E., Berthon, P., Dussert, C., Calvo, F., and Martin, P. M. Estradiol, and EGF requirements for cell cycle progression of normal mammary epithelials in culture. Int. J. Cancer, 49: 932-937, 1991.
18. Dickson, R. B., Salomon, D. S., and Lippman M. E. Tyrosine kinase receptor-nuclear protooncogene interactions in breast cancer. Cancer Treat. Res., 67: 249-273, 1992.
19. Gill, P. G., Tilley, W. D., DeYoung, N. J., Lensink, I. L., Dixon, P. D., and Horsfall, D. J. Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF. Breast Cancer Res. Treat., 20: 53-62, 1991.
20. Eppstein, D. A., Marsh, Y. V., Schryver, B. B., and Bertics, P. J. Inhibition of epidermal growth factor/transforming growth factor-α stimulated cell growth by a synthetic peptide. J. Cell. Physiol., 141: 420-430, 1989.
21. Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Mayes, E. L. V., Whittle, N., Watesfield, M. D., and Seebing, P. H. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (Lond.), 309: 425-428, 1984.
22. Jardines, L., Weiss, M., Fowble, B., and Greene, M. Neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology, 61: 268-282, 1993.
23. Rajkumar, T., and Gullick, W. J. The type 1 growth factors receptors in human breast cancer. Breast Cancer Res. Treat., 29: 3-9, 1994.
24. Souttou, B., Hamelin, R., and Crepin, M. FGF2 as an autocrine growth factor for immortal human breast epithelial cells. Cell. Growth & Differ., 5: 615-623, 1994.
25. Musgrove, E. A., and Sutherland, R. L. Acute effects of growth factors on T-47D breast cancer cell cycle progression. Eur. J. Cancer, 29: 2273-2279, 1993.
26. Pusztai, L., Lewis, C. E., and McGee, J. O. Epidermal growth factor, insulin-like growth factor-1 and basic fibroblast growth factor modulate the cytostatic effect of tumor necrosis factor-α on the breast cancer cell line, T47D. Cytokine, 5: 169-172, 1993.
27. Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J. Natl. Cancer Inst., 86: 356-362, 1994.
28. Arteaga, C. L., Tandon, A. K., Von Hoff, D. D., and Osborne, C. K. Transforming growth factor β: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res., 48: 3898-3904, 1988.
29. Hosobuchi, M., and Stampfer, M. R. Effects of transforming growth factor-β on the growth of human mammary epithelial cells in culture. In Vitro Cell. & Dev. Biol., 25: 705-713, 1989.
30. Wakefield, L. M., Colletta, A. A., McCune, B. K., and Sporn, M. B. Roles for transforming growth factor-β in the genesis, prevention, and treatment of breast cancer. In: R. B. Dickson and M. E. Lippman (eds.), Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer, pp. 96-136. Boston: Kluwer Academic Publishers, 1991.
31. Escot, C., Theillet, C., Lidereau, R., Spyratos, F., Champeme, M. H., Gest, J., and Callahan, R. Genetic alteration of the c-myc protooncogene in human primary breast carcinomas. Proc. Natl. Acad. Sci. USA, 83: 4834-4838, 1986.
32. Cline, M., Battifora, H., and Yokota, J. J. Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of diagnosis. J. Clin. Oncol., 5: 999-1006, 1987.
33. Bonilla, M., Ramirez, M., Lopez-Cuento, J., and Gariglio, P. In vivo amplification and rearrangements of c-myc oncogene in human breast tumors. J. Natl. Cancer Inst., 80: 665-671, 1988.
34. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T., and Kishimoto, T. Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell, 63: 1149-1157, 1990.
35. Estrov, Z., Samal, B., Lapushin, R., Kellokumpu-Lehtinen, P., Sahin, A. A., Kurzrock, R., Talpaz, M., and Aggarwal, B. B. Leukemia inhibitory factor binds to human breast cancer cells and stimulates their proliferation. J. Interferon Cytokine Res., 15: 905-913, 1995.
36. Zhang, L., Chang, C. J., Bacus, S. S., and Hung, M. C. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. Cancer Res., 55: 3890-3896, 1995.
37. Bacus, S. S., Kiguchi, K., Chin, D., King, C. R., and Huberman, E. Differentiation of cultured human breast cancer cells (AU-565 and MCF-7) associated with loss of cell surface HER/neu antigen. Mol. Carcinog., 3: 350-352, 1990.
38. Thoma, B., Bird, T. A., Friend, D. J., Gearing, D. P., and Dower, S. K. Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J. Biol. Chem., 269: 6215-6222, 1994.
39. Shoyab, M., Plowman, G. D., McDonald, V. L., Bradley, J. G., and Todaro, G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science (Washington DC), 324: 1074-1076, 1989.
40. Boulton, T. G., Stahl, N., and Yancopoulos, G. D. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induce tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem., 269: 11648-11653, 1994.
41. Schieven, G. L., Kallestad, J. C., Brown, J. T., Ledbetter, J. A., and Linsley, P. S. Oncostatin M induces tyrosine phosphorylation in endothelial cells and activation of p62 (yes) tyrosine kinase. J. Immunol., 149: 1676-1682, 1992.
42. Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, M., Davis, S., Shoyab, M., Yancopoulos, G. D., and Kishimoto, T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc. Natl. Acad. Sci. USA, 89: 10998-11001, 1992.
43. Kishimoto, T., Taga, T., and Akira, S. Cytokine signal transduction. Cell, 76: 253-262, 1994.
44. Lutticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., Kishimoto, T., Barbieri, G., Pellegrini, S., Sendtner, M., Heinrich, P. C., and Horn, F. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science (Washington DC), 263: 89-92, 1994.
45. Narazaki, M., Witthun, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ihie, J., Kishimoto, T., and Taga, T. Activation of Jak2 kinase mediated by the interleukin-6 signal transducer gp130. Proc. Natl. Acad. Sci. USA, 91: 2285-2289, 1994.
46. Akira, S., Nishio, Y., Inoke, M., Wang, X. J., Wei, S., Matsusaka, T., Yoshida, K., Sudo, T., Naruto, M., and Kishimoto, T. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 P91-related transcription factor involved in gp130-mediated signaling pathway. Cell, 77: 63-71, 1994, 1994.
47. Feldman, G. M., Petricoin, E. F., III, David, M., Larner, A. C., and Finbloom, D. S. Cytokines that associate with the signal transducer gp130 activate the interferon-induced transcription factor p91 by tyrosine phosphorylation. J. Biol. Chem., 269: 10747-10752, 1994.
48. Darnell, J. R., J. E., Kerr, I. M., and Stark, G. R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Washington DC), 264: 1415-1421, 1994.
49. Malik, N., Graves, D., Shoyab, M., and Purchio, A. F. Amplification and expression of heterologous oncostatin M in Chinese hamster ovary cells. DNA Cell Biol., 11: 453-459, 1992.
50. Salvatori, R., Bockman, R. S., and Guidon, P. T., Jr. A simple modification of the Peppel/Baglioni method for RNA isolation from cell culture. Biotechniques, 13: 510-512, 1992.
51. Virca, G. D., Northemann, W., Shiels, B. R., Widera, G., and Broome, S. Simplified Northern blot hybridization using 5% sodium dodecyl sulfate. Biotechniques, 8: 370-371, 1990.